Table 1.
Analyte | Action | Source |
---|---|---|
IL-1 | Increased | [19, 60, 62, 134, 135] |
IL-1b | Increased | [19, 60, 68, 70, 71, 74, 134, 136-139] |
IL-2 | Increased Decreased |
[48, 63, 140-142] |
IL-4 | Increased Decreased |
[108, 143] |
IL-6 | Increased Decreased |
[62, 108, 138, 144-148] |
IL-8 | Increased | [19, 82, 149] |
IL10 | Increased Decreased |
[83, 103, 139, 142, 150-153] |
IL12 | Increased Decreased |
[19, 108, 112, 114, 139, 154, 155] |
IL-18 | Increased | [68, 70, 71] |
IL-23 | Increased | [19, 137] |
TNF-a | Increased Decreased |
[19, 136, 144, 150] [108, 136-140, 151, 155] |
Interferon γ | Increased | [63, 66, 136] |
Thrombospondin 1 | Increased | [112, 115] |
Prostaglandin E2 | Increased | [35, 151, 156] |
Prostacyclin | Increased | [23, 157, 158] |
Indoleamine 2-3 dioxygenase | Increased | [112, 115] |
Intracellular Sodium | Increased | [13] |
Intracellular Potassium | Increased Decreased |
[68, 71] |
Intracellular Calcium | Increased Decreased |
[14, 48, 70, 136, 137, 146, 157, 159-163] |
Cyclic AMP | Increased | [108, 114, 142, 154, 164, 165] |
Cyclic GMP | Increased | [20, 137] |
Nitric Oxide | Increased | [20, 43, 74, 137, 150, 157, 158] |
Prostaglandin D2 | Increased | [23, 164] |
Thromboxane B2 | Increased | [166] |
Arachidonic Acid | Increased | [23, 79, 82] |